New CFO and Board Member at Miach Orthopaedics

Westborough, Massachusetts-based Miach Orthopaedics, Inc. has appointed Christopher Joyce as vice president and chief financial officer and Kevin Sidow to its board of directors.

Joyce has more than 30 years of financial operations experience. His experience includes leading companies from launch through commercialization. He has “raised over $2 billion of public and private debt and equity, including two public offerings and over $200 million of venture financing.”

Joyce has served as a consulting CFO for the past two years. In that role, he has worked with biotech and medical device startups. Prior to his consulting work, he served as CFO for FRX Polymers, Elemé Medical, and Percardia.

OTW spoke with Joyce about what he is most looking forward to in his new role at Miach Orthopaedics. He informed OTW, “I’m looking forward to working with an amazing team to improve the standard of care for ACL [anterior cruciate ligament] surgeries for many years to come.”

Sidow has more than 35 years of orthopedics experience and is a familiar name in the medical device industry. Most recently, Sidow served as president and CEO for Moximed, Inc. and, prior to his time at Moximed, served as president and CEO for St. Francis Medical Technologies Inc. Sidow has also served as the worldwide president of DePuy Inc., where he oversaw the global orthopedic, spine, trauma, and sports medicine businesses.

Sidow told OTW, “I am excited to join Miach [Orthopaedics] at such a critical time, when their experienced management team is bringing truly innovative, less invasive technology to patients.”

Miach Orthopaedics is a privately held company focused on the development of “bio-engineered surgical implants for connective tissue restoration.” The company is currently focused on its Bridge-Enhanced® ACL Repair (BEAR^®) Implant, a bio-engineered implant designed for ACL repair.

Last year, Miach Orthopaedics received De Novo approval from the U.S. Food and Drug Administration for its BEAR^® Implant. This fall, Miach Orthopaedics plans to commercially launch the BEAR^® Implant in the United States.

Miach Orthopaedics President and CEO Martha Shadan commented, “We are thrilled to welcome Chris [Joyce], who has an impressive background in managing finance and operations for medical device startups, and Kevin [Sidow], a highly accomplished and well-respected leader in bringing orthopedic products to market.”

Shadan continued, “Both Chris [Joyce] and Kevin [Sidow] bring expertise that will benefit Miach [Orthopaedics] during this pivotal period of company growth.”